Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. REOLYSIN®

   ONCOLYTICS BIOTECH INC

   Osteosarcoma

   phase 2 · mab · completed

   1 trial →

2. REOLYSIN®

   ONCOLYTICS BIOTECH INC

   Carcinoma, Non-small Cell Lung

   phase 2 · mab · completed

   1 trial →

3. REPRAB - MITO 36

   Fondazione Telethon ETS

   recurrent ovarian cancer

   phase 2 · small molecule · active

   1 trial →

4. REPRINT

   Fondazione Telethon ETS

   Collecting Duct Carcinoma, Medullary Renal cell Carcinoma

   phase 2 · small molecule · active

   1 trial →

5. RESCUE-HUB

   Istituto Gentili S.r.l.

   unresectable hepatocellular carcinoma (HCC)

   phase 2 · small molecule · active

   1 trial →

6. REVERSE

   Fondazione Telethon ETS

   Pseudomyxoma peritonei patients with high tumor burden.

   phase 2 · small molecule · active

   1 trial →

7. RITUXIMAB, Golcadomide

   Fondazione Telethon ETS

   Diffuse Large B-cells non-Hodgkin Lymphoma

   phase 2 · small molecule · active

   1 trial →

8. RMC-4630

   Revolution Medicines

   Non-Small Cell Lung Cancer

   phase 2 · small molecule · completed

   1 trial →

9. RMC-4630

   Revolution Medicines

   Solid Tumor

   phase 2 · small molecule · completed

   1 trial →

10. RMC-6236

    Revolution Medicines

    Colorectal Cancer

    phase 2 · small molecule · active

    1 trial →

11. RMC-6236

    Revolution Medicines

    Non-small Cell Lung Cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

12. RMC-9805

    Revolution Medicines

    Lung Cancer

    phase 2 · small molecule · active

    1 trial →

13. RMC-LUNG-101C

    Revolution Medicines

    Lung Cancer

    phase 2 · small molecule · active

    1 trial →

14. RO7197597

    Hoffmann-La Roche

    Grade 1 Endometrial Cancer

    phase 2 · small molecule · active

    1 trial →

15. RO7247669

    Hoffmann-La Roche

    Melanoma

    phase 2 · small molecule · completed

    1 trial →

16. RO7247669

    Hoffmann-La Roche

    Unresectable or Metastatic Melanoma

    phase 2 · small molecule · active

    1 trial →

17. RUBIDIUM CHLORIDE

    Pari Pharma GmbH

    Kidney carcinoma

    phase 2 · small molecule · active

    1 trial →

18. RX-3117

    Processa Pharmaceuticals

    Metastatic Pancreatic Cancer

    phase 2 · small molecule · completed

    1 trial →

19. RX-3117

    Processa Pharmaceuticals

    Solid Tumor

    phase 2 · small molecule · completed

    1 trial →

20. Radiation: Radiation Therapy；Biological: Personalized tumor peptide vaccine

    Hospital Authority, Hong Kong

    Advanced Tumors

    phase 2 · other · active

    1 trial →

21. Radio-guided sentinel node biopsy

    Hospital Authority, Hong Kong

    Cancer of the Breast

    phase 2 · other · terminated

    1 trial →

22. Radiochemoimmunotherapy

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 2 · other · active

    1 trial →

23. Radiotherapy

    The First People's Hospital of Lianyungang

    Cholangiocarcinoma

    phase 2 · other · terminated

    1 trial →

24. Radiotherapy Combined with Anlotinib and a Microtubule Inhibitor

    The First People's Hospital of Lianyungang

    HER2-Negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

25. Radium-223 dichloride (Xofigo, BAY88-8223)

    Bayer HealthCare AG

    Breast Neoplasms

    phase 2 · small molecule · completed

    1 trial →

26. Raltitrexed

    The First People's Hospital of Lianyungang

    Inoperable Esophageal Cancer Stage I-III

    phase 2 · small molecule · active

    1 trial →

27. Raludotatug Deruxtecan

    Daiichi Sankyo

    Advanced/metastatic solid tumors including gynecological cancers (endometrial cancer, cervical cancer, and nonhigh- grade serous ovarian cancer) and genitourinary cancers (urothelial cancer and ccRCC)

    phase 2 · small molecule · active

    1 trial →

28. Raludotatug Deruxtecan (R-DXd)

    Merck KGaA, Darmstadt, Germany

    Gastrointestinal Cancer

    phase 2 · mab · active

    1 trial →

29. Ramucirumab

    Eli Lilly and Company

    Gastric Adenocarcinoma

    phase 2 · small molecule · completed

    1 trial →

30. Recombinant Human Endostatin Injection

    The First People's Hospital of Lianyungang

    Locally Advanced Squamous Non-small Cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

31. Recombinant anti-PD-1 humanized monoclonal antibody injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Sarcoma, Soft Tissue

    phase 2 · small molecule · active

    1 trial →

32. Recombinant human endostatin

    The First People's Hospital of Lianyungang

    Stage III Non-small-Cell Lung Cancer

    phase 2 · small molecule · completed

    1 trial →

33. Regorafenib

    United Therapeutics Europe Ltd

    Adenocarcinoma of the Gastroesophageal Junction

    phase 2 · small molecule · terminated

    1 trial →

34. Relacorilant

    CORCEPT THERAPEUTICS INC

    Recurrent Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

35. Relacorilant 150 mg once daily (QD)

    CORCEPT THERAPEUTICS INC

    Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

36. Relacorilant 150 mg once daily (QD)

    CORCEPT THERAPEUTICS INC

    Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

37. Relacorilant with nab-paclitaxel

    CORCEPT THERAPEUTICS INC

    Solid Tumors

    phase 2 · small molecule · completed

    1 trial →

38. Relatlimab

    Bristol-Myers Squibb

    Neoplasms by Site

    phase 2 · mab · completed

    1 trial →

39. Relugolix

    Takeda

    Prostate Cancer

    phase 2 · small molecule · completed

    1 trial →

40. Repotrectinib (TPX-0005)

    Turn Therapeutics

    Advanced Solid Tumors

    phase 2 · small molecule · active

    1 trial →

41. Revumenib

    Syndax Pharmaceuticals

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    2 trials →

42. Revumenib

    Syndax Pharmaceuticals

    Leukemia

    phase 2 · small molecule · active

    1 trial →

43. Revumenib

    Syndax Pharmaceuticals

    Colorectal Cancer

    phase 2 · small molecule · completed

    1 trial →

44. Rezvilutamide

    Nanjing Zenshine Pharmaceuticals

    Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

45. Rezvilutamide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Metastatic Hormone-Sensitive Prostate Cancer

    phase 2 · small molecule · active

    1 trial →

46. Rilvegostomig, Rilvegostomig

    AstraZeneca AB

    Advanced Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, stage III unresectable Non-small Cell Lung Cancer (Protocol Parts A-B), stage IV Non-small Cell Lung Cancer (Protocol Parts A-E).

    phase 2 · small molecule · active

    1 trial →

47. Ritonavir

    Abbott Australasia Pty Ltd

    Sarcoma, Kaposi

    phase 2 · small molecule · completed

    1 trial →

48. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diffuse Large B Cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

Frequently asked questions